Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who underwent active monitoring had similar two-year invasive ipsilateral breast cancer recurrence rates as those who underwent guideline-concordant treatment, according to results from the COMET clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
Moving to polluted areas can lead to weight gain in kids
A large natural experiment in Catalonia shows that moving to areas with higher levels of air pollution is associated with weight gain in young children.
August 1, 2023